October 4, 2023
FDA Approves Ryzumvi Eye Drops for Reversal of Pharmacologically-Induced Mydriasis: What You Need to Know
The U.S. Food and Drug Administration (FDA) has granted approval [...]
Category: New Product
September 3, 2023
New FDA Approval: IZERVAY
The FDA’s recent approval of IZERVAY (avacincaptad pegol), [...]
August 23, 2023
Introducing OVITZ Technology at Compton Eye Associates
At Compton Eye Associates, we are thrilled to announce the [...]
August 15, 2023
Introducing Xdemvy: A Breakthrough in Demodex Treatment
Are you struggling with red, itchy eyes? Have you been diagnosed [...]
August 5, 2023
Wave Technology: A New Era in Customized Contact Lenses
We are thrilled to announce that Compton Eye Associates is now [...]
August 3, 2023
New FDA Approval: VEVYE
We are pleased to inform our patients at Compton Eye Associates [...]
July 13, 2023
New FDA Approval: MYDCOMBI
We have exciting news for patients at Compton Eye Associates: the [...]
July 6, 2023
Advanced Vision, Advanced Comfort: The U.S. Debut of INFUSE Multifocal SiHy Contacts
As we step into the summer of 2023, a groundbreaking advancement [...]
May 9, 2023
New: Acuvue OASYS MAX 1-Day Contact Lenses
Johnson & Johnson Vision, a global leader in eye health, has [...]
April 3, 2023
New FDA Approval: SYFOVRE
We are excited to announce a significant advancement in the [...]